Adverse effects of low-flow oxygen therapy

Respiratory Care

Volumn 45, Issue 1, 2000, Pages 54-64

  Benditt, Joshua O ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Absorption atelectasis; Fire hazard; Hypercarbia; Liquid oxygen; Low flow oxygen therapy; Oxygen concentrator; Oxygen cylinder; Oxygen hazard; Oxygen toxicity; Parenchymal lung injury

Indexed keywords

OXYGEN;

ATELECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; HYPERCAPNIA; LUNG INJURY; OXYGEN THERAPY; OXYGEN TOXICITY; PATHOPHYSIOLOGY;

ACCIDENT PREVENTION; ADAPTATION, PHYSIOLOGICAL; BURNS; EQUIPMENT FAILURE; HUMANS; OXYGEN INHALATION THERAPY; SMOKING;

EID: 0033969343     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Priestley J. Experiments and observations on different kinds of air Vol II, Sections III-V. In: The discovery of oxygen, Part I. Alembic Club Reprint No. 7 London: Simpkin, Marshall, Hamilton, Kent; 1894: 29-103.
2. Balentine J. Pathology of oxygen toxicity. New York: Academic Press: 1982.
3. Smith J. The pathological effects due to increase of oxygen tension in the air breathed J Physiol (London) 1899;24:19-35.
4. Clark JM, Lambertsen CJ. Pulmonary oxygen toxicity: a review Pharmacol Rev 1971;23(2):37-133.
5. Haugaard N. Cellular mechanisms of oxygen toxicity. Physiol Rev 1968;48(2):311-373.
6. Carraway MS, Prantadost CA. Oxygen toxicity. Respir Care Clin N Am 1999;5(2):265-295.
7. Lodato RF. Oxygen toxicity. Crit Care Clin 1990;6(3):749-765
8. Comroe J, Dripps R, Dumke P, et al. Oxygen toxicity: the effect of inhalation of high concentration of oxygen for 24 hours on normal men at sea level and at a simulated altitude of 18.000. JAMA 1945; 128:710-717.
9. Sackner MA, Hirsch JA, Epstein S, Rywlin AM. Effect of oxygen in graded concentrations upon tracheal mucous velocity: a study in anesthetized dogs. Chest 1976;69(2):164-167.
10. Wagner PD, Laruvuso RB, Uhl RR, West JB. Continuous distributions of ventilation-perfusion ratios in normal subjects breathing air and 100 per cent O2. J Clin Invest 1974;54(1):54-68.
11. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 1986;48:721-731.
12. Fracica PJ, Knapp MJ, Crapo JD. Patterns of progression and markers of lung injury in rodents and subhuman primates exposed to hyperoxia. Exp Lung Res 1988;14 Suppl:869-885.
13. Bowden DH, Adamson YR. Reparative changes following pulmonary cell injury ultrastructural, cytodynamic, and surfactant studies in mice after oxygen exposure. Arch Pathol 1971;92(4):279-283.
14. Crapo JD, Barry BE, Foscue HA, Shelburne J, Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980;122(1):123-143.
15. Davis WB, Rennard SI, Bitterman PB, Crystal RG. Pulmonary oxygen toxicity: early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med 1983;309(15):878-883.
16. Barber RE, Hamilton WK. Oxygen toxicity in man: a prospective study in patients with irreversible brain damage. N Engl J Med 1970;283(27):1478-1484.
17. Hyde RW, Rawson AJ. Unintentional ratrogenic oxygen pneumonitis response to therapy. Ann Intern Med 1969;71(3):517-531.
18. Kaplan HP, Robinson FR, Kapanci Y, Weibel ER, Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. I. Clinical and light microscopic studies. Lab Invest 1969;20(1):94-100.
19. Thomas AN, Hall AD. Mechanism of pulmonary injury after oxygen therupy. Am J Surg 1970;120(2):255-263.
20. Churg A, Golden J, Fligiel S, Hogg JC. Bronchopulmonary dyplasia in the adult. Am Rev Respir Dis 1983;127(1):117-120.
21. Pierson DJ. The toxicity of low-flow oxygen therapy. Respir Care 1983;28(7):889-897.
22. Petty TL, Stanford RE, Neff TA. Continuous oxygen therapy in chronic airway obstrction: obsen ations on possible oxygen toxicity and survival Ann Int Med 1971;75(3):361-367.
23. Stewart BN, Hood CI, Block AJ Long-term results of continuous oxygen therapy as sea level. Chest 1975;68(4):486-492.
24. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93(3):391-398.
25. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Report of the Medical Research Council Working Party. Lancet 1981;1(8222): 681-686
26. Yusa T, Crapo JD. Freeman BA. Hyperoxia enhances lung and liver nuclear superoxide generation Biochim Biophys Acta 1984;798(2): 167-174.
27. Freeman BA. Topolosky MK. Crapo JD. Hyperoxia increases oxygen radical production in rat lung homogenates. Arch Biochem Biophys 1982;216(2):477-484
28. Freeman BA. Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria J Biol Chem 1981; 256(21):10986-10992.
29. Freeman BA, Crapo JD. Biology of disease. free radicals and tissue injury. Lab Invest 1982;47(5)412-426
30. Saltzman HA. Fridovich I oxygen toxicity. Introduction to a protective enzyme: Superoxide dismutase (editorial). Circulation 1973; 48(5):921-923.
31. Grave GD, Kennedy C, Sokoioff L. Impairment of growth and development of the rat brain by hyperoxata at atmospheric pressure. J Neurochem 1972;19:(1):187-194
32. Clark J. Current concepts in oxygen toxicity in: Bacrach A. Matzen M, editors. Underwater Physiology VII. Prodeedings of the Seventh Symposium on Underwater Physiology. Bethesda, MD: Undersea Medical Society. 1981;3-21.
33. Crapo JD. Tierney DF Superoxide dismutase and pulmonary oxygen toxicity. Am J Physiol 1974;226(6):1401-1407.
34. Donald K. Neurological effects of oxygen. Lancet 1949,ii:1056-1057.
35. Nunn J. Ventilatory failure. In: Nunn J. editor. Nunn's applied respiratory physiology. Oxford. UK 1993;421-428.
36. Hanson CW 3rd, Marshall BE, Frasch HF. Marshall C. Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Crit Care Med 1996;24(1):23-28.
37. Aubier M. Murciano D. Milic-Emili J, Touaty E, Daghfous J, Pariente R. Derenne JP. Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 1980; 122(5);747-754.
38. Sassoon CS, Hassell KT, Mahutte CK. Hyperoxie-induced hypercapnia in stable chronic obstructive pulmonary disease. Am Rev Respir Dis 1987;135(4):907-911.
39. Spearman C. Sheldon R. Egan D. Egan's fundamentals of respiratory therapy. St Louis: CV Mosby; 1982.
40. Clamann H. Fire hazards. Ann NY Acad Sci 1965;117:814.
41. West GA, Primeau P. Nonmedical hazards of long-term oxygen therapy Respir Care 1983;28(7):906-912.
42. Blackmer R. Fire safety of OECO oxygen enricher (pamphlet). Schenectady: Oxygen Enrichment Company. Jun 3. 1982.
43. Stark RD, Bishop JM, New method for oxygen therapy in the home using an oxygen concentrator. Br Med J 1973;2(858):105-106
44. Lampton L. Home and out-patient oxygen therapy, In: Brashear R. Rhodes M. editors. Chronic obstructive lung disease: clinical treatment and management. St Louis: CV Mosby; 1978.
45. McLaughlin AJ Jr, Allergic contact dermatitis from oxygen cannulas. Respir Care 1980;25(10):1024-1026.